Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
3.620
-0.880 (-19.56%)
At close: Feb 11, 2026, 4:00 PM EST
3.500
-0.120 (-3.31%)
Pre-market: Feb 12, 2026, 5:41 AM EST
Polaryx Therapeutics Market Cap
Polaryx Therapeutics has a market cap or net worth of $171.38 million as of February 12, 2026.
Market Cap
171.38M
Enterprise Value
165.64M
1-Year Change
n/a
Ranking
Category
Stock Price
3.62
Market Cap Chart
Since February 2, 2026, Polaryx Therapeutics's market cap has decreased from $1.66B to $171.38M, a decrease of -89.66%. That is a compound annual growth rate of -100.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 171.38M | -19.56% |
| Feb 10, 2026 | 213.04M | -24.11% |
| Feb 9, 2026 | 280.75M | -33.45% |
| Feb 6, 2026 | 421.83M | -44.31% |
| Feb 5, 2026 | 757.49M | -28.89% |
| Feb 4, 2026 | 1.07B | 2.51% |
| Feb 3, 2026 | 1.04B | -37.29% |
| Feb 2, 2026 | 1.66B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 204.39M |
| SAB Biotherapeutics | 200.42M |
| Tonix Pharmaceuticals Holding | 194.34M |
| Sol-Gel Technologies | 186.65M |
| Humacyte | 186.16M |
| Milestone Pharmaceuticals | 182.85M |
| Crescent Biopharma | 182.59M |
| Kalaris Therapeutics | 181.79M |